Get App
Download App Scanner
Scan to Download
Advertisement

Q3 Results Today: Bata India, Zydus Lifesciences, Aurobindo Pharma, Pfizer Among 184 Firms To Declare Earnings

P N Gadgil Jewellers, Trident, Sri Lotus Developers and Realty and Bajaj Electricals are some of the other names that will announce quarterly results.

Q3 Results Today: Bata India, Zydus Lifesciences, Aurobindo Pharma, Pfizer Among 184 Firms To Declare Earnings
Photo source: NDTV Profit
  • About 184 companies will announce Q3 results for October-December on Feb 9
  • Investors will focus on revenue, profit, margins, and possible dividend declarations
  • Companies like Bata India, Pfizer, Aurobindo Pharma, and Zydus Lifesciences will report
Did our AI summary help?
Let us know.

About 184 companies are set to announce their Q3 results on Feb. 9, covering the October-December performance. Investors will closely watch key numbers such as revenue, profit, and margins to assess the performance of these companies. Some companies may also declare dividends alongside their earnings. Most firms are also expected to hold earnings calls to discuss results, offer insights and interact with investors and analysts. These Q3 announcements will provide a clear picture of corporate performance for the quarter and help investors make informed decisions going forward.

Major Companies To Announce Q3 Results On Feb. 9

  • Bata India Ltd.
  • Sri Lotus Developers and Realty Ltd.
  • Muthoot Microfin Ltd.
  • Pfizer Ltd.
  • P N Gadgil Jewellers Ltd.
  • Sky Gold And Diamonds Ltd.
  • Trident Ltd.
  • Zydus Lifesciences Ltd.
  • Apollo Micro Systems Ltd.
  • Asarfi Hospital Ltd.
  • Aurobindo Pharma Ltd.
  • Bajaj Electricals Ltd.
  • Cholamandalam Financial Holdings Ltd.

Zydus Lifesciences Q2FY26 Results

Zydus Lifesciences Ltd. reported consolidated revenue from operations up 17% year on year to Rs 6,123 crore, compared with Rs 5,237 crore in Q2FY25. Ebitda for the quarter increased 38% YoY to Rs 2,016 crore from Rs 1,461 crore last year. The Ebitda margin improved sharply to 32.9% from 27.9%, marking an expansion of 500 basis points. Net profit for the quarter jumped 38% YoY to Rs 1,257 crore from Rs 911 crore in the year-ago period. 

Aurobindo Pharma Q2FY26 Results

Aurobindo Pharma's consolidated revenue from operations rose 6.3% YoY to Rs 8,286 crore, compared with Rs 7,796 crore in the same quarter last year. Ebitda, before forex and other income, increased 7.1% to Rs 1,678 crore from Rs 1,566 crore. The Ebitda margin improved slightly to 20.3% from 20.1%. Profit after tax stood at Rs 848 crore, up 3.8% from Rs 817 crore in Q2FY25. 

Trident Q2FY26 Results

Trident reported its consolidated Q2FY26 revenue from operations at Rs 1,787 crore from Rs 1,713 crore in the year-ago quarter. Ebitda declined 2.5% to Rs 232 crore from Rs 238 crore. The Ebitda margin also fell to 12.8% from 13.78% last year. Net profit rose 9% YoY to Rs 91 crore, compared with Rs 83 crore in Q2FY25.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search